Dual stimuli-responsive dendronized prodrug derived from poly(oligo-(ethylene glycol) methacrylate)-based copolymers for enhanced anti-cancer therapeutic effect
Source abstract
Abstract
In this study, we developed an enzyme- and pH-responsive dendronized poly(oligo-(ethylene glycol) methacrylate) (pOEGMA)-doxorubicin (DOX) polymeric prodrug, which combined the pOEGMA structure with a degradable peptide dendron. The introduction of the dendron in the prodrug hindered the entanglement of brush oligo-(ethylene glycol) (OEG) chains, allowed the prodrug to possess dual stimuli-responsiveness, and mediated self-assembly of the polymeric prodrug to form stable nanoparticles (NPs). Brush conformation of polyethylene glycol (PEG) side chains endowed the NPs with long-term circulation with a half-life of 16.0 h. The dual-responsive dendritic structure enhanced cellular uptake of NPs and facilitated drug release in response to overexpressed cathepsin B and an acidic pH in the tumor microenvironment, resulting in an enhanced therapeutic effect with a tumor inhibition rate of 72.9% for 4T1 tumor-bearing mice. The NPs were demonstrated to possess great hemocompatibility and biosafety. Therefore, this strategy could provide great insight for the design of poly(oligo-(ethylene glycol) methacrylate)-based copolymers as drug delivery carriers. STATEMENT OF SIGNIFICANCE: We propose a dual-stimuli-responsive dendronized strategy for improving the cancer therapeutic effect of the poly(oligo-(ethylene glycol) methacrylate) (pOEGMA)-based drug conjugates. The introduction of the functional dendron promotes self-assembly of the polymeric prodrug into nanoparticles, hindering the entanglement of brush oligo-(ethylene glycol) (OEG) chains in the conjugated drugs. The obtained poly OEGMA-GFLG-Dendron-NH-N=DOX nanoparticles maintains long circulation, while addresses the drug release issue due to the presence of high-density PEG. The drug delivery system exhibits a high therapeutic potentcy with negligible side effects.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Dendrimers and Hyperbranched Polymers · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Tumor delivery of macromolecular drugs based on the EPR effect10.1016/j.addr.2010.03.011 ↗
2. Principles of nanoparticle design for overcoming biological barriers to drug delivery10.1038/nbt.3330 ↗
3. Designing smart polymer conjugates for controlled release of payloads10.1021/acs.chemrev.8b00006 ↗
4. Engineered nanoparticles for drug delivery in cancer therapy10.1002/anie.201403036 ↗
5. Polymer conjugates as anticancer nanomedicines10.1038/nrc1958 ↗
6. Impact of surface polyethylene glycol (PEG) density on biodegradable nanoparticle transport in mucus ex vivo and distribution in vivo10.1021/acsnano.5b03876 ↗
7. PEGylation for enhancing nanoparticle diffusion in mucus10.1016/j.addr.2017.08.010 ↗
8. Amphiphilic peptide dendritic copolymer-doxorubicin nanoscale conjugate self-assembled to enzyme-responsive anti-cancer agent10.1016/j.biomaterials.2014.07.059 ↗
9. Stimuli-sensitive linear–dendritic block copolymer–drug prodrug as a nanoplatform for tumor combination therapy10.1002/adma.202108049 ↗
10. Polymeric conjugates for drug delivery10.1021/cm2031569 ↗
11. What is the future of PEGylated therapies?10.1517/14728214.2015.1113254 ↗
12. PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics10.1021/nl302638g ↗
13. Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution10.1016/j.addr.2011.09.009 ↗
14. Supramolecular nanoscale assemblies for cancer diagnosis and therapy10.1016/j.jconrel.2015.06.034 ↗
15. Evading immune cell uptake and clearance requires PEG grafting at densities substantially exceeding the minimum for brush conformation10.1021/mp400703d ↗
16. Core-clickable PEG- branch -azide bivalent-bottle-brush polymers by ROMP: grafting-through and clicking-to10.1021/ja108441d ↗
17. Well-defined degradable brush polymer–drug conjugates for sustained delivery of paclitaxel10.1021/mp3004868 ↗
18. A degradable brush polymer–drug conjugate for pH-responsive release of doxorubicin10.1039/C4PY01194E ↗
19. Well-defined diblock brush polymer–drug conjugates for sustained delivery of paclitaxel10.1039/C4BM00458B ↗
20. Theranostic unimolecular micelles based on brush-shaped amphiphilic block copolymers for tumor-targeted drug delivery and positron emission tomography imaging10.1021/am5002585 ↗
21. Modulating the cellular immune response of oligonucleotides by brush polymer-assisted compaction10.1002/smll.201701432 ↗
22. Effect of polymer side chains on drug delivery properties for cancer therapy10.1166/jbn.2017.2466 ↗
23. Synthesis and direct imaging of ultrahigh molecular weight cyclic brush polymers10.1002/anie.201101860 ↗
24. Arginine functionalized peptide dendrimers as potential gene delivery vehicles10.1016/j.biomaterials.2012.03.030 ↗
25. Dendronized heparin−doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy10.1016/j.biomaterials.2012.12.017 ↗
26. Dendronized supramolecular polymers10.1039/C4CC03119A ↗
27. Synthesis and thermo-/pH- dual responsive properties of poly(amidoamine) dendronized poly(2-hydroxyethyl) methacrylate10.1021/ma1000783 ↗
28. Synthesis of poly(OEOMA) using macromonomers via “Grafting-Through” ATRP10.1021/acs.macromol.5b01592 ↗
29. Stimuli-sensitive biodegradable and amphiphilic block copolymer-gemcitabine conjugates self-assemble into a nanoscale vehicle for cancer therapy10.1021/acsami.6b15232 ↗
30. Enzyme- and pH-sensitive branched polymer–doxorubicin conjugate-based nanoscale drug delivery system for cancer therapy10.1021/acsami.6b02006 ↗
31. Amphiphilic toothbrushlike copolymers based on poly(ethylene glycol) and poly(ε-caprolactone) as drug carriers with enhanced properties10.1021/bm100116g ↗
32. Bioapplications of RAFT polymerization10.1021/cr9001403 ↗
33. Drug delivery: brushing off antigenicity10.1038/s41551-016-0019 ↗
34. Stimuli-responsive nanocarriers for drug delivery10.1038/nmat3776 ↗
35. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect10.1016/j.addr.2010.04.009 ↗
36. Branched polymer-based redox/enzyme-activable photodynamic nanoagent to trigger STING-dependent immune response for enhanced therapeutic effect
37. Synergistic therapy of a naturally-inspired glycopolymer-based biomimetic nanomedicine harnessing tumor genomic instability10.1002/adma.202104594 ↗
38. Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines10.3892/ijo.2016.3558 ↗
39. Effect of the polymer architecture on the structural and biophysical properties of PEG–PLA nanoparticles10.1021/acsami.5b01423 ↗
40. Targeted drug delivery to tumors: Myths, reality and possibility10.1016/j.jconrel.2011.06.001 ↗
41. Programmed size-changeable nanotheranostic agents for enhanced imaging-guided chemo/photodynamic combination therapy and fast elimination10.1002/adma.202100398 ↗
42. Cascade drug-release strategy for enhanced anticancer therapy10.1016/j.matt.2020.10.002 ↗
43. Polyprodrug nanomedicines: an emerging paradigm for cancer therapy
44. Enhanced antitumor efficacy by a cascade of reactive oxygen species generation and drug release10.1002/anie.201908997 ↗
45. Tumor-specific drug release and reactive oxygen species generation for cancer chemo/chemodynamic combination therapy
46. GSH-sensitive polymeric prodrug: synthesis and loading with photosensitizers as nanoscale chemo-photodynamic anti-cancer nanomedicine10.1016/j.apsb.2021.05.003 ↗